While the risks associated with COVID-19 generally have decreased over time due to prior exposure to the vaccines and the virus, some people remain at elevated risk, such as the elderly and immunocompromised. The updated COVID-19 vaccines and, in some cases, a new monoclonal antibody can provide increased protection for this group. “At this point, many people have had multiple vaccines and we are seeing a lot less severe and life-threatening illness, especially, Read More
2024-04-24